GeneDx Holdings (WGS) Cash From Operations

Annual CFO

-$28.50 M
+$151.65 M+84.18%

December 31, 2024


Summary


Performance

WGS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWGScash flowmetrics:

Quarterly CFO

-$3.18 M
+$1.21 M+27.58%

December 31, 2024


Summary


Performance

WGS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWGScash flowmetrics:

TTM CFO

-$28.50 M
+$26.68 M+48.35%

December 31, 2024


Summary


Performance

WGS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherWGScash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WGS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+84.2%+89.3%+84.2%
3 y3 years+85.0%+89.3%+84.2%
5 y5 years-52.2%+89.3%+84.2%

WGS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+91.1%at high+96.4%at high+91.1%
5 y5-year-52.2%+91.1%at high+96.4%at high+91.1%
alltimeall time-52.2%+91.1%at high+96.4%at high+91.1%

GeneDx Holdings Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$28.50 M(-84.2%)
-$3.18 M(-27.6%)
-$28.50 M(-48.3%)
Sep 2024
-
-$4.39 M(-2.4%)
-$55.17 M(-40.0%)
Jun 2024
-
-$4.50 M(-72.6%)
-$92.00 M(-34.7%)
Mar 2024
-
-$16.41 M(-45.0%)
-$141.00 M(-21.7%)
Dec 2023
-$180.15 M(-43.6%)
-$29.86 M(-27.6%)
-$180.15 M(-16.2%)
Sep 2023
-
-$41.23 M(-22.9%)
-$214.94 M(-18.0%)
Jun 2023
-
-$53.50 M(-3.7%)
-$262.08 M(-10.6%)
Mar 2023
-
-$55.56 M(-14.1%)
-$293.22 M(-8.1%)
Dec 2022
-$319.15 M
-$64.65 M(-26.8%)
-$319.15 M(+4.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$88.36 M(+4.4%)
-$306.49 M(+6.0%)
Jun 2022
-
-$84.64 M(+3.9%)
-$289.06 M(+25.8%)
Mar 2022
-
-$81.49 M(+56.8%)
-$229.72 M(+20.6%)
Dec 2021
-$190.43 M(+104.5%)
-
-
Dec 2021
-
-$51.98 M(-26.7%)
-$190.43 M(+37.5%)
Sep 2021
-
-$70.94 M(+180.4%)
-$138.45 M(+105.1%)
Jun 2021
-
-$25.30 M(-40.1%)
-$67.51 M(+59.9%)
Mar 2021
-
-$42.21 M
-$42.21 M
Dec 2020
-$93.13 M(+397.3%)
-
-
Dec 2019
-$18.73 M
-
-

FAQ

  • What is GeneDx Holdings annual cash flow from operations?
  • What is the all time high annual CFO for GeneDx Holdings?
  • What is GeneDx Holdings annual CFO year-on-year change?
  • What is GeneDx Holdings quarterly cash flow from operations?
  • What is the all time high quarterly CFO for GeneDx Holdings?
  • What is GeneDx Holdings quarterly CFO year-on-year change?
  • What is GeneDx Holdings TTM cash flow from operations?
  • What is the all time high TTM CFO for GeneDx Holdings?
  • What is GeneDx Holdings TTM CFO year-on-year change?

What is GeneDx Holdings annual cash flow from operations?

The current annual CFO of WGS is -$28.50 M

What is the all time high annual CFO for GeneDx Holdings?

GeneDx Holdings all-time high annual cash flow from operations is -$18.73 M

What is GeneDx Holdings annual CFO year-on-year change?

Over the past year, WGS annual cash flow from operations has changed by +$151.65 M (+84.18%)

What is GeneDx Holdings quarterly cash flow from operations?

The current quarterly CFO of WGS is -$3.18 M

What is the all time high quarterly CFO for GeneDx Holdings?

GeneDx Holdings all-time high quarterly cash flow from operations is -$3.18 M

What is GeneDx Holdings quarterly CFO year-on-year change?

Over the past year, WGS quarterly cash flow from operations has changed by +$26.68 M (+89.34%)

What is GeneDx Holdings TTM cash flow from operations?

The current TTM CFO of WGS is -$28.50 M

What is the all time high TTM CFO for GeneDx Holdings?

GeneDx Holdings all-time high TTM cash flow from operations is -$28.50 M

What is GeneDx Holdings TTM CFO year-on-year change?

Over the past year, WGS TTM cash flow from operations has changed by +$151.65 M (+84.18%)